Benjamin Edwards Inc’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.64M	Buy	55,506 +870	+2%	+$45.9K	0.03%	469
2025 Q4	$2.87M	Buy	54,636 +416	+0.8%	+$24.9K	0.03%	420
2025 Q3	$3.51M	Sell	54,220 -3,540	-6%	-$203K	0.04%	376
2025 Q2	$2.81M	Buy	57,760 +6,845	+13%	+$265K	0.04%	392
2025 Q1	$1.73M	Buy	50,915 +5,853	+13%	+$248K	0.02%	448
2024 Q4	$1.77M	Buy	45,062 +12,359	+38%	+$584K	0.03%	466
2024 Q3	$1.54M	Buy	32,703 +32,465	+13,641%	+$1.65M	0.02%	485
2024 Q2	$13K	Sell	238 -131	-36%	-$7.58K	﹤0.01%	611
2024 Q1	$25K	Buy	369 +30	+9%	+$2.15K	0.01%	552
2023 Q4	$21K	Sell	339 -165	-33%	-$9.12K	﹤0.01%	535
2023 Q3	$23K	Buy	504 +13	+3%	+$671	0.01%	525
2023 Q2	$28K	Sell	491 -67	-12%	-$3.8K	0.01%	513
2023 Q1	$25K	Buy	558 +30	+6%	+$1.46K	0.01%	520
2022 Q4	$21K	Buy	528 +107	+25%	+$5.68K	0.01%	503
2022 Q3	$28K	Sell	421 -78	-16%	-$5.65K	0.01%	473
2022 Q2	$30K	Buy	499 +19	+4%	+$1.12K	0.01%	476
2022 Q1	$30K	Buy	480 +10	+2%	+$628	0.01%	510
2021 Q4	$36K	Buy	470 +74	+19%	+$6.46K	0.01%	453
2021 Q3	$44K	Sell	396 -14	-3%	-$1.76K	0.03%	319
2021 Q2	$66K	Sell	410 -68	-14%	-$8.27K	0.05%	249
2021 Q1	$58K	Sell	478 -67	-12%	-$10.1K	0.04%	242
2020 Q4	$83K	Sell	545 -233	-30%	-$27.5K	0.06%	203
2020 Q3	$65K	Buy	778 +48	+7%	+$4.26K	0.05%	197
2020 Q2	$54K	Hold	730	–	–	0.05%	194
2020 Q1	$31K	Buy	730 +109	+18%	+$5.63K	0.03%	208
2019 Q4	$38K	Buy	621 +54	+10%	+$2.95K	0.08%	139
2019 Q3	$23K	Buy	567 +21	+4%	+$1K	0.05%	158
2019 Q2	$26K	Buy	546 +268	+96%	+$10.7K	0.06%	149
2019 Q1	$10K	Buy	+278	New	+$9.61K	0.05%	202